Detection of serum level of interleukin-17 in patients with HBeAg-Positive chronic hepatitis B treated with interferon alpha

Liu Li,Wang Ke,Zhao Yingren
DOI: https://doi.org/10.3969/j.issn.1000-7377.2010.03.028
2010-01-01
Abstract:Objective:To assess the significance of serum intheleukin-17(IL-17)in patients with HBeAg-positive chronic hepatitis B(CHB)during interferon alpha treatment.Methods:ELISA was used to test the serum levels of IL-17 in the eleven health control and the twenty patients with CHB prior to treatment.The serum levels of IL-17,HBeAg titer,liver function and HBV DNA of the patients were detected in the different weeks of interferon alpha treatment.Results:The serum IL-17 levels of the patients with HBeAg-positive chronic hepatitis B were not significantly increased than healthy people.During interferon alpha treatment,the IL-17 levels of response group significantly increased in 18 weeks,but that of non-response group always fluctuated at the baseline level.The serum IL-17 levels of patients which HBeAg were negtive after treatment were significantly increased in 18 weeks.Conclusion:The Th17 cell might be involved in the interforon's end-stage antivirus of the patients with HBeAg-positive chronic hepatitis B by producing IL-17.
What problem does this paper attempt to address?